# Gangrene Market > Gangrene Market Research Report Information, by Type (Dry Gangrene, Wet Gangrene, Gas Gangrene), Treatment (Vascular Surgery, Hyperbaric Oxygen Chamber, Amputation), End User (Hospital, Clinic, Rehabilitation Center) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.76% - **2024:** $ 1.52 Million - **2025:** $ 1.62 Million - **2035:** $ 2.82 Million - **Key Players:** Johnson & Johnson (US), Smith & Nephew (GB), MediWound Ltd. (IL), Acelity L.P. Inc. (US), 3M Company (US), B. Braun Melsungen AG (DE), ConvaTec Group PLC (GB), Mölnlycke Health Care AB (SE), Integra LifeSciences Holdings Corporation (US) **Report ID:** MRFR/Pharma/1343-HCR · **Pages:** 90 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/gangrene-market-1875 --- ## Market Summary ## **Gangrene Market Overview** The gangrene market is projected to reach USD 2,926.6 Million by 2030 at 8.3% CAGR during the forecast period 2022-2030. Gangrene is defined as the death of body tissue(s) due to a lack of blood flow. A range of chronic conditions, as well as post-traumatic, post-surgical, and spontaneous reasons, can cause it. Dry, wet, and gas gangrene are the three types of gangrene. The risk of gas gangrene has increased as the occurrence of severe traumatic injury has increased, leading to the growth of the gangrene market. Gangrene is a disorder in which bodily tissues die as a result of a severe bacterial infection or a lack of blood supply. An injury, underlying sickness, or infection could be the cause of a lack of blood supply. **The following are some of the causes of gangrene:** **There is a shortage of blood-** The shortage of blood supplies in one’s body with oxygen and nourishment. It also provides antibodies to your immune system, which helps it fight infections. Your cells cannot survive without an adequate blood supply, and your tissue deteriorates. **Infection-  ** A bacterial infection that goes untreated might lead to gangrene. **An injury caused by a traumatic event-** Open wounds from gunshot wounds or crushing injuries from vehicle accidents can allow bacteria to enter the body. Gangrene can develop if germs infect tissues and are not treated. Diabetes is one of the variables that increase the chance of developing gangrene. If you have diabetes, your body either doesn't create enough insulin (which helps your cells absorb blood sugar) or is resistant to insulin's effects. Blood arteries can be damaged by high blood sugar levels, reducing or halting blood flow to a section of the body. Blood clots and hardened and restricted arteries (atherosclerosis) can potentially impede blood flow to a part of the body. Any process that produces stress to your skin and underlying tissue, such as an injury or frostbite, raises your risk of developing gangrene, particularly if you have an underlying condition that limits blood flow to the wounded area. Smokers are more likely to develop gangrene. These all factors, therefore, increase the gangrene market value during the forecast period. **COVID-19 Analysis** There have been a few instances of persons developing dry gangrene in their fingers and toes because of blood coagulation issues caused by COVID-19 (coagulopathy). This link needs to be confirmed by more research. The coronavirus strain that caused the disastrous Covid-19 epidemic in India is the most contagious to date which has increased the Gangrene Market Trends. Doctors are now trying to figure out if it's also more serious. Doctors in India have connected the so-called Delta variety to hearing loss, severe gastrointestinal disturbances, and blood clots leading to gangrene, symptoms not generally observed in Covid users. Early evidence indicated that the now-dominant strain is associated with a higher incidence of hospitalization in England and Scotland. Delta has expanded to nearly 60 nations in the last six months, prompting travel restrictions. Higher rates of transmission relative to previous varieties, as well as a decrease in vaccination effectiveness, have made understanding the strain's impacts even more important. Covid-19 sufferers in India are suffering from stomach pain, nausea, vomiting, loss of appetite, hearing loss, and joint pain, to name a few symptoms. During the last two months, some patients have developed microthrombi, or minute blood clots, that have caused affected tissue to die and develop gangrene. According to local media, doctors are also discovering clots growing in blood veins that supply the intestines, causing patients to have stomach pain as their only symptom. ## **Gangrene Market Dynamics** ### **Gangrene Market Drivers** The rise in the occurrence of severe traumatic injury is likely to support the Market Growth in the foreseeable future. Furthermore, the rising prevalence of diabetes and the complications that come with it are expected to fuel the expansion of the Market. Also, the rising healthcare for infectious illness treatment in developed nations would open new chances for the Market in the approaching years. Diabetes Incidence Is Increasing Across the Globe, thus, boosting the Gangrene Market growth. ### **Gangrene Market Restraints** The absence of effective therapy for the disease is expected to stymie the gangrene market value throughout the forecast period. The lack of healthcare facilities in many developed and developing countries may pose an additional hurdle to the market growth.Over the market Analysis period, however, the high cost of treatment and managing the illness is expected to act as a major limitation on the growth of the gangrene treatment medicines market. The gangrene market offers extensive market information for technologies, prognosis, and remedies. Some of the data variables offered on the market include prevalence, incidence, mortality, and adherence rates. In the future years, technological advances and developments will provide profitable opportunities for Global gangrene Market participants. Even during the COVID era, gangrene is becoming increasingly prevalent among the world's population. As a result of technological advancements, the installed base of various types of products for the Global gangrene Market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the Market are all increasing. ## **Gangrene Market Segmentation** ### **Based on the type** ### **Based on the treatment** ### **Based on the end-user** ## **Gangrene Market Regional Analysis** North America is the largest gangrene market in the world. Because of the strong presence of significant key players, North America dominates the gangrene treatment industry. Furthermore, rising healthcare costs and increasing technological advancements in the healthcare sector would propel the gangrene treatment market in the area to new heights throughout the forecast period. Europe is Gangrene's second-largest market, and it is predicted to expand fast. The Asia-Pacific region is predicted to develop at the quickest rate in the Gangrene industry. Due to an increase in the number of cases of gangrene affecting the mouth, nose, and lips, Asia-Pacific is expected to see considerable growth in the gangrene treatment market. Furthermore, the region's gangrene treatment market is expected to develop in the next years due to an increase in the older population. ## **Gangrene Market Competitive Insights** Company overview, financials, market potential, investment in research and development, new market initiatives, company strengths and weaknesses, product launch, clinical trial pipelines, application dominance, and technology lifeline curve are all included in the gangrene treatment market competitive landscape. The information presented above is only about the firms' concentration on the gangrene treatment market.  **Some of the major key players in the gangrene market are:** **Recent Developments** **Gangrene Market Report Overview** The report depicts the current market landscape in detail, including historical and projected market size in terms of value and volume, technical advancements, and market controlling factors. The report also includes detailed information and plans for the industry's top major players. From technology-based analysis to market portfolio strategies, a market analysis of target competitors can be studied. The gangrene treatment market is examined, with data on market size broken down by country, kind, therapy type, treatment type, end-users, and area. The gangrene treatment market report examines opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market, as well as market share, new developments, and the impact of market players. ## Market Drivers ### Aging Population The aging population worldwide is a critical driver of the Global Gangrene Market Industry. Older adults are more susceptible to chronic conditions, such as vascular diseases and diabetes, which can lead to gangrene. As the demographic shift towards an older population continues, the demand for effective management and treatment options for gangrene is expected to rise. This trend is particularly relevant in developed countries where healthcare systems are adapting to meet the needs of an aging populace. Consequently, the market is anticipated to grow significantly, reflecting the increasing healthcare demands of older individuals. ### Rising Incidence of Diabetes The increasing prevalence of diabetes globally contributes significantly to the Global Gangrene Market Industry. Diabetes can lead to complications such as [peripheral artery disease](https://www.marketresearchfuture.com/reports/peripheral-artery-disease-market-1540) and neuropathy, which elevate the risk of gangrene. In 2024, the market is projected to reach 1.9 USD Billion, driven by the need for effective treatment options for diabetic patients. As the number of individuals diagnosed with diabetes continues to rise, the demand for advanced wound care products and therapies is likely to expand, thereby influencing market growth. This trend underscores the importance of addressing diabetic complications in the context of gangrene. ### Advancements in Medical Technology Technological innovations in medical devices and treatment methodologies are reshaping the Global Gangrene Market Industry. The introduction of advanced imaging techniques, such as MRI and CT scans, enhances the early detection of gangrene, facilitating timely intervention. Moreover, the development of novel wound care products, including bioengineered skin substitutes, is expected to improve patient outcomes. As these technologies become more widely adopted, they may contribute to a projected market growth rate of 7.86% CAGR from 2025 to 2035. This evolution in medical technology signifies a pivotal shift in how gangrene is diagnosed and treated. ### Increasing Awareness and Education There is a growing emphasis on public awareness and education regarding gangrene and its risk factors within the Global Gangrene Market Industry. Health organizations are actively promoting information campaigns aimed at educating the public about the symptoms, prevention, and treatment options for gangrene. This heightened awareness is likely to lead to earlier diagnosis and treatment, which can significantly reduce the incidence of severe cases. As a result, the market may experience a surge in demand for educational resources and healthcare services, ultimately contributing to the projected market value of 4.36 USD Billion by 2035. ### Rising Incidence of Traumatic Injuries The Global Gangrene Market Industry is also influenced by the rising incidence of traumatic injuries, which can lead to gangrene. Accidents, natural disasters, and combat-related injuries often result in severe wounds that may become infected, increasing the risk of gangrene. As global awareness of trauma care improves, there is a growing need for effective treatment options to manage these injuries. This trend is likely to drive market growth as healthcare providers seek advanced solutions to prevent complications associated with traumatic injuries, thereby enhancing patient care. ## Future Outlook The Gangrene Market is projected to grow at a 5.76% CAGR from 2025 to 2035, driven by advancements in wound care technologies and increasing prevalence of diabetes. **New opportunities:** - Development of advanced antimicrobial dressings for gangrene treatment. - Expansion of telemedicine platforms for remote patient monitoring. - Investment in regenerative medicine to enhance tissue repair and recovery. By 2035, the Gangrene Market is expected to achieve substantial growth, reflecting evolving healthcare needs. ## Segment Insights ### By Application: Wound Care (Largest) vs. Surgical Treatment (Fastest-Growing) In the Gangrene Market, the application segments are diverse, but Wound Care currently holds the largest market share due to its critical role in the treatment of gangrene. This segment encompasses various products and therapies dedicated to managing and healing wounds, making it essential for patient recovery. Surgical Treatment, although smaller in market share compared to Wound Care, is witnessing rapid growth as more advanced surgical techniques and technologies are being developed. Wound Care (Dominant) vs. Surgical Treatment (Emerging) Wound Care stands out as the dominant application in the Gangrene Market, driven by its comprehensive range of treatment options that cater to both acute and chronic cases. This segment is characterized by innovative dressings, topical agents, and advanced therapies designed to accelerate wound healing and prevent further complications. On the other hand, Surgical Treatment is emerging as a significant segment due to increasing advancements in surgical procedures and the rising incidence of severe gangrene cases requiring operative intervention. Enhanced surgical techniques have led to improved patient outcomes, thus propelling the growth of this segment as healthcare professionals increasingly rely on surgeries alongside conventional treatment methods. ### By Type of Gangrene: Dry Gangrene (Largest) vs. Wet Gangrene (Fastest-Growing) In the Gangrene Market, Dry Gangrene holds the largest market share among the various types of gangrene, primarily due to its prevalent association with peripheral artery diseases and diabetes. This segment's dominance is further driven by the aging population, where conditions leading to Dry Gangrene become more common. In contrast, Wet Gangrene is emerging as the fastest-growing segment, primarily because of rising incidences related to infections and trauma, as well as increased awareness and diagnosis rates. The growth trends in the Gangrene Market reflect a significant need for effective treatments for both Dry and Wet Gangrene. The rising cases of chronic diseases and the increasing focus on wound care are major drivers. Furthermore, advancements in medical research and technology are facilitating better diagnostic tools and treatment options, enhancing the management of these conditions. Dry Gangrene (Dominant) vs. Wet Gangrene (Emerging) Dry Gangrene is characterized by the slow loss of blood flow to the limbs, leading to tissue necrosis without the presence of infection. This type of gangrene is often associated with chronic illnesses such as diabetes and vascular diseases, making it a critical concern within the healthcare sector. The segment benefits from well-established treatment protocols and a growing emphasis on preventive measures. In contrast, Wet Gangrene emerges as a result of bacterial infections and is marked by rapid tissue destruction. This segment is gaining attention due to an increasing prevalence of traumatic injuries and postoperative complications. The dynamics of Wet Gangrene are shifting towards innovative treatment approaches, including advanced wound care products and [hyperbaric oxygen therapy](https://www.marketresearchfuture.com/reports/hyperbaric-oxygen-therapy-market-30668), positioning it as a significant player in the Gangrene Market. ### By End User: Hospitals (Largest) vs. Clinics (Fastest-Growing) In the Gangrene Market, Hospitals remain the largest segment, accounting for a significant share of the overall market due to their comprehensive facilities and access to advanced treatment options. Clinics, on the other hand, are emerging rapidly as more patients seek immediate and localized care, leading to an increase in their market share. Home care settings and ambulatory surgical centers also contribute to the market, but to a lesser extent compared to Hospitals and Clinics. Hospitals (Dominant) vs. Clinics (Emerging) Hospitals play a dominant role in the Gangrene Market due to their capacity to provide specialized care and manage complex cases efficiently. They are equipped with advanced medical technologies and have access to a wider range of treatment options, making them the preferred choice for severe gangrene cases. Clinics represent an emerging segment, catering to patients seeking timely interventions for gangrene management. Their growing popularity is attributed to the increased focus on outpatient care and the rise in patient awareness about early treatment. Both segments are crucial to the overall market dynamics, with Hospitals emphasizing comprehensive care while Clinics prioritize accessibility. ### By Treatment Method: Surgical Intervention (Largest) vs. Hyperbaric Oxygen Therapy (Fastest-Growing) In the Gangrene Market, Surgical Intervention holds the largest market share, owing to its critical role in treating severe cases of gangrene through debridement and amputation when necessary. This method is widely recognized for its effectiveness in reducing infection and complications associated with necrotic tissue. Antibiotic Therapy follows as a significant method, utilized to combat bacterial infections related to gangrene, while Wound Care Management plays a supportive role, focusing on maintaining proper wound hygiene and care. Moreover, Hyperbaric Oxygen Therapy is gaining traction as an emerging treatment option that shows promise in enhancing wound healing through increased oxygen delivery to the affected tissues. Surgical Intervention (Dominant) vs. Wound Care Management (Emerging) Surgical Intervention is a dominant treatment method in the Gangrene Market due to its direct and effective approach to remove infected tissue and prevent the spread of gangrene. It is often the first line of defense in critical cases, providing rapid intervention. Conversely, Wound Care Management is viewed as an emerging segment, essential for postoperative care and preventing further complications. With an emphasis on wound care products and management techniques, it supports healing and recovery. As healthcare professionals focus on holistic treatment approaches, Wound Care Management's importance is expected to grow, complementing the swift actions taken through Surgical Interventions. ### By Severity Level: Severe (Largest) vs. Critical (Fastest-Growing) The 'Severity Level' segment in the Gangrene Market is characterized by distinct classifications: Mild, Moderate, Severe, and Critical. The Severe category holds the largest market share, reflecting its prevalence in clinical settings where aggressive treatment is often necessary. Meanwhile, the Critical segment is emerging rapidly, driven by an increase in severe cases and heightened awareness of the condition. Mild and Moderate levels indicate milder symptoms but show less impact on overall market dynamics. Severe (Dominant) vs. Critical (Emerging) The Severe segment is recognized as the dominant category within the Gangrene Market, representing a substantial portion of cases that necessitate immediate medical attention. This segment includes instances of gangrene that require surgical intervention or advanced treatment modalities. The Critical segment is emerging as a key focus area for healthcare providers due to the rising incidence of critical infections and co-morbid conditions that exacerbate gangrene. Factors such as an aging population and an uptick in chronic diseases contribute to the fast growth of the Critical segment, making it a priority for research and development in new treatment options. ## Regional Market Share Analysis ### North America : Market Leader in Gangrene Treatment North America holds a significant market share of 76% in the gangrene market as of 2024, driven by advanced healthcare infrastructure, high prevalence of diabetes, and increasing awareness of wound care. Regulatory support from agencies like the FDA has accelerated the approval of innovative treatments, enhancing market growth. The rising geriatric population and the demand for effective wound management solutions further contribute to this robust market landscape. The United States is the leading country in this region, hosting major players such as Johnson & Johnson, 3M Company, and Acelity L.P. Inc. The competitive landscape is characterized by continuous innovation and strategic partnerships among key players. The presence of advanced medical facilities and a strong focus on research and development are pivotal in maintaining North America's leadership in the gangrene market. ### Europe : Emerging Market with Growth Potential Europe accounts for 40% of The Gangrene, driven by increasing incidences of chronic wounds and a growing elderly population. Regulatory frameworks in countries like Germany and the UK are fostering innovation in wound care products, which is crucial for market expansion. The emphasis on healthcare quality and patient safety is also propelling demand for advanced treatment options, making Europe a key player in the global market. Leading countries in this region include Germany, the UK, and France, where major companies like Smith & Nephew and B. Braun Melsungen AG are actively involved. The competitive landscape is marked by a mix of established firms and emerging startups focusing on innovative solutions. The presence of strong healthcare systems and supportive regulations further enhances the market's growth prospects. ### Asia-Pacific : Rapidly Growing Market Segment The Asia-Pacific region holds a market share of 30% in the gangrene market, driven by rising healthcare expenditures and increasing awareness of wound care management. Countries like China and India are witnessing a surge in diabetic patients, leading to a higher demand for effective treatment solutions. Government initiatives aimed at improving healthcare infrastructure are also contributing to market growth, making this region a focal point for future investments. China and India are the leading countries in this market, with a growing presence of key players such as MediWound Ltd. and Integra LifeSciences Holdings Corporation. The competitive landscape is evolving, with both local and international companies striving to capture market share. The increasing focus on research and development, along with strategic collaborations, is expected to drive innovation in the gangrene treatment sector in this region. ### Middle East and Africa : Emerging Market with Challenges The Middle East and Africa represent a nascent segment of the gangrene market, accounting for only 6% of the global share. However, the region is witnessing gradual growth due to increasing healthcare investments and rising awareness of chronic wound management. The demand for advanced medical technologies and treatments is on the rise, driven by a growing population and the prevalence of diabetes and other chronic conditions. Countries like South Africa and the UAE are leading the market in this region, with a focus on improving healthcare infrastructure. The competitive landscape is characterized by a mix of local and international players, although challenges such as regulatory hurdles and limited access to advanced treatments persist. The presence of key players like ConvaTec Group PLC and Mölnlycke Health Care AB is crucial for driving market growth in this region. ## Competitive Benchmarking The Gangrene Market is currently characterized by a competitive landscape that is both dynamic and multifaceted. Key growth drivers include an increasing prevalence of chronic wounds, advancements in wound care technologies, and a heightened focus on patient outcomes. Major players such as Johnson & Johnson (US), Smith & Nephew (GB), and Acelity L.P. Inc. (US) are strategically positioned to leverage these trends. Johnson & Johnson (US) emphasizes innovation in wound care products, while Smith & Nephew (GB) focuses on expanding its product portfolio through strategic acquisitions. Acelity L.P. Inc. (US) is enhancing its operational focus on regenerative medicine, which collectively shapes a competitive environment that is increasingly reliant on technological advancements and strategic partnerships.In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in the context of global economic fluctuations. The Gangrene Market appears to be moderately fragmented, with a mix of established players and emerging companies. The collective influence of these key players is significant, as they drive innovation and set industry standards, thereby shaping market dynamics. In November Johnson & Johnson (US) announced the launch of a new advanced wound care product line aimed at improving healing times for patients with gangrene. This strategic move is likely to enhance their market share by addressing unmet needs in wound management, thereby reinforcing their commitment to innovation and patient care. The introduction of this product line may also stimulate competitive responses from other players in the market. In October Smith & Nephew (GB) completed the acquisition of a smaller biotech firm specializing in bioactive wound dressings. This acquisition is strategically important as it allows Smith & Nephew (GB) to integrate cutting-edge technology into its existing product offerings, potentially enhancing its competitive edge in the gangrene treatment segment. The move reflects a broader trend of consolidation within the industry, as companies seek to bolster their technological capabilities. In September Acelity L.P. Inc. (US) entered into a partnership with a leading research institution to develop next-generation wound healing therapies. This collaboration is indicative of a growing trend towards innovation through partnerships, which may lead to breakthroughs in treatment options for gangrene. Such strategic alliances are likely to play a crucial role in shaping the future landscape of the market. As of December current competitive trends in the Gangrene Market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are increasingly shaping the landscape, allowing companies to pool resources and expertise. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on innovation, technology, and supply chain reliability. This transition may redefine how companies position themselves in the market, emphasizing the importance of advanced solutions over traditional pricing strategies. ## Recent News & Developments - Customers and patients will benefit from novel healing solutions developed by market players across the care continuum, resulting in proven clinical outcomes. - The businesses are also expanding and developing innovative and differentiated goods and services to meet the changing demands of patients, providers, and consumers in the healthcare industry. ## Report Scope | MARKET SIZE 2024 | 1.52(USD Million) | | --- | --- | | MARKET SIZE 2025 | 1.62(USD Million) | | MARKET SIZE 2035 | 2.82(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.76% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Johnson & Johnson (US), Smith & Nephew (GB), MediWound Ltd. (IL), Acelity L.P. Inc. (US), 3M Company (US), B. Braun Melsungen AG (DE), ConvaTec Group PLC (GB), Mölnlycke Health Care AB (SE), Integra LifeSciences Holdings Corporation (US) | | Segments Covered | Application, Type of Gangrene, Treatment Method, Patient Demographics | | Key Market Opportunities | Advancements in wound care technologies enhance treatment options in the Gangrene Market. | | Key Market Dynamics | Rising prevalence of diabetes and vascular diseases drives demand for advanced gangrene treatment options and technologies. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the current valuation of the Gangrene Market as of 2024?** A: The Gangrene Market was valued at 1.52 USD Million in 2024. **Q: What is the projected market valuation for the Gangrene Market in 2035?** A: The Gangrene Market is projected to reach 2.82 USD Million by 2035. **Q: What is the expected CAGR for the Gangrene Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Gangrene Market during the forecast period 2025 - 2035 is 5.76%. **Q: Which companies are considered key players in the Gangrene Market?** A: Key players in the Gangrene Market include Johnson & Johnson, Smith & Nephew, and MediWound Ltd. **Q: What are the primary applications within the Gangrene Market?** A: The primary applications include Surgical Treatment, Wound Care, Diabetes Management, and Infection Control. **Q: How does the market segment by type of gangrene?** A: The market segments by type of gangrene into Dry Gangrene, Wet Gangrene, Gas Gangrene, and Internal Gangrene. **Q: What are the main end-user segments in the Gangrene Market?** A: Main end-user segments include Hospitals, Clinics, Home Care Settings, and Ambulatory Surgical Centers. **Q: What treatment methods are utilized in the Gangrene Market?** A: Treatment methods include Surgical Intervention, Antibiotic Therapy, Hyperbaric Oxygen Therapy, and Wound Care Management. **Q: How is the Gangrene Market segmented by severity level?** A: The market is segmented by severity level into Mild, Moderate, Severe, and Critical. **Q: What is the valuation range for the Wound Care application in the Gangrene Market?** A: The valuation range for the Wound Care application is between 0.35 and 0.65 USD Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/gangrene-market-1875*